Drugs / KN5001
last change 13 days ago re-read 3 minutes ago

KN5001

Developed for
pulmonary coin lesion
Investigated by
Ruitherapeutics Co., LTD · The First Affiliated Hospital with Nanjing Medical University

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT07185035 Sep 2025 → Sep 2026 overdue pulmonary coin lesion The First Affiliated Hospital with Nanjing Medical University Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as KN5001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT07185035 ↗